CPI-169
* Required Fields.
Please complete the form below and you will get the price list in 1 minute.
* Required Fields.
Please complete the form below and we will contact you shortly.
* Required Fields.
Please complete the form below and we will contact you shortly.
CAS No. | 1450655-76-1 | Cat. No. | BCP12650 |
Name | CPI-169 | ||
Synonyms | CPI169;CPI 169; | ||
SMILES | |||
Chemical Name | |||
Formula | C27H36N4O5S | M. Wt | 528.66 |
Purity | 98% | Storage | Store at 4-8°C |
Description | in vitro: CPI-169, a representative compound from that effort, inhibits the catalytic activity of PRC2 with an IC50 of < 1nM, decreases cellular levels of H3K27me3 with an EC50 of 70 nM, and triggers cell cycle arrest and apoptosis in a variety of cell lines. Importantly, compound treatment triggers a sequence of downstream functional consequences of EZH2 inhibition whereby apoptosis is not induced before ten days of continuous target engagement. in vivo: Administered subcutaneously at 200 mpk twice daily (BID), CPI-169 is well tolerated in mice with no observed toxic effect or body weight loss. In the present study we show that CPI-169 treatment led to tumor growth inhibition (TGI) of an EZH2 mutant KARPAS-422 DLBCL xenograft. The TGI is proportional to the dose administered and to the reduction of the pharmacodynamic marker H3K27me3. The highest dose, 200 mpk, BID led to complete tumor regression. Since CHOP (cyclophosphamide, doxorubicin, vincristine and prednisone) is the standard |
Recommend Products
More >Tags:CPI-169 supplier,CPI-169 purchase,CPI-169 manufacturer,CPI-169 distributor,CPI-169 cost,CPI-169 buy,CPI-169 for sale